| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President and CEO | President
1 company
Kovach John S serves as a President and CEO at LIXT. Across recent SEC filings that breaks down to 1 buy and 0 sells. Those positions are worth an estimated $7.3M at current prices.
The biggest single holding is LIXT (~$7.3M) as President and CEO. Net of sales, the recent Form 4 record there shows accumulation of 21,100 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 30, 2020 | LIXT Lixte Biotechnology Holdings, Inc. | President and CEO | Buy | 21,100 | $4.75 | $100,225.00 | +1.4% |